RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome

Apoptosis, necroptosis and pro-inflammatory NF-κB-dependent signaling are repressed by receptor-interacting serine/threonine-protein kinase 1 (RIPK1). A recent paper in Immunity describes a small molecule inducing the proteolytic degradation of RIPK1. In preclinical experiments, this RIPK1 inhibitor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jonathan G. Pol, Andrea Checcoli, Manuela Lizarralde-Guerrero, Guido Kroemer
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2024-12-01
coleção:	OncoImmunology
Assuntos:	Cancer immunotherapy immune checkpoint inhibitor immunogenic cell death necroptosis radiotherapy
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/2162402X.2024.2425465
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!